ipamorelin ghs growth hormone secretagogue CJC 1295 Ipamorelin: A Scientific Perspective on
Description
Int J Pharm 441(12):535543
Helicobacter (2007) 12:23843
The data generated during this phase help define the dose range that may be explored in subsequent studies and contribute to understanding exposure-response relationships, pharmacokinetic behavior and safety considerations associated with the investigational compound
More targeted than steroids with fewer systemic side effects
Bull Chem Soc Jpn 84:13621367
